多重耐药细菌的粪便携带及相关危险因素:一项点患病率研究的结果
2019年9月至2020年1月,巴黎市区11家教学医院对某日全部住院患者进行点患病率调查,直肠拭子筛查产碳青霉烯酶革兰阴性杆菌(CP-GNB)、耐万古霉素屎肠球菌(VRE)和产超广谱β-内酰胺酶肠杆菌目(ESBL-PE)携带率及相关危险因素。2396例中364例(15.2%)携带至少一种多重耐药菌,包括CP-GNB 29例(1.2%)、VRE 13例(0.5%)、ESBL-PE 338例(14%)。
要点
- 2396例住院患者中15.2%携带至少一种多重耐药菌,ESBL-PE携带率14%,CP-GNB 1.2%,VRE 0.5%。
- 既往法国本土以外住院、既往抗菌治疗和既往ESBL-PE携带是CP-GNB和/或VRE携带的主要危险因素。
- 15例(ESBL-PE携带者的4.4%、CP-GNB/VRE携带者的36.6%)同时携带CP-GNB/VRE与ESBL-PE。
核心结论
- CP-GNB和VRE的低患病率可能反映法国限制CP-GNB和VRE菌株院内传播的政策。
研究设计与样本
- 2019年9月至2020年1月,在巴黎市区11家教学医院对某日全部住院患者进行点患病率研究,由专职护士记录患者访谈和直肠拭子筛查结果。
- 拭子接种于选择性显色培养基,并使用GeneXpert®系统处理。
主要发现
- 2396例患者中364例(15.2%)检出至少一种多重耐药细菌分离株,包括CP-GNB携带者29例(1.2%)、VRE携带者13例(0.5%)和ESBL-PE携带者338例(14%)。
- 15例患者(ESBL-PE携带者的4.4%、CP-GNB/VRE携带者的36.6%)同时携带CP-GNB/VRE与ESBL-PE。
- 29例CP-GNB携带者中的7例和13例VRE携带者中的7例,其筛查样本中的碳青霉烯酶产生和vanA仅通过Xpert®检测发现。
- 29例携带者的34株CP-GNB分离株中,OXA-48基因占主导(13/34)。
- 338例ESBL-PE携带者中回收372株分离株,主要为大肠埃希菌(61.2%);379例儿童中1.1%携带CP-GNB/VRE菌株,12.4%携带ESBL菌株。
关键数值与推荐
- 既往法国本土以外住院、既往抗菌治疗和既往ESBL-PE携带是与CP-GNB和/或VRE携带相关的主要危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Since 2003, incidences of carbapenemase-producing Gram-negative bacilli (CP-GNB) and vancomycin-resistant Enterococcus faecium (VRE) have steadily increased in France. We therefore conducted a point prevalence study to estimate carriage rates of CP-GNB, VRE and ESBL-producing Enterobacterales (ESBL-PE) and associated risk factors. METHODS: Between September 2019 and January 2020, all inpatients hospitalized on a given day in 11 teaching hospitals in the Paris urban area were eligible. Patient interviews and rectal swab screening results were recorded by dedicated nurses. The swabs were plated onto selective chromogenic media and processed using the GeneXpert® system. RESULTS: Of 2396 patients, 364 (15.2%) yielded at least one multiresistant bacterial isolate, including 29 CP-GNB carriers (1.2%), 13 VRE carriers (0.5%) and 338 ESBL-PE carriers (14%). In 15 patients (4.4% of ESBL-PE carriers and 36.6% of CP-GNB/VRE carriers), concomitant CP-GNB/VRE and ESBL-PE carriage was observed. In 7/29 CP-GNB and 7/13 VRE carriers, carbapenemase production and vanA in the screening samples was only detected with Xpert® tests. The OXA-48 gene was predominant in 13/34 CP-GNB isolates from 29 carriers. From the 338 ESBL-PE carriers, 372 isolates were recovered, mainly Escherichia coli (61.2%). Among 379 children, 1.1% carried a CP-GNB/VRE strain, and 12.4% carried an ESBL strain. Previous hospitalization outside mainland France, previous antimicrobial treatment and previous ESBL-PE carriage were the main risk factors associated with CP-GNB and/or VRE carriage. CONCLUSIONS: The low CP-GNB and VRE prevalence likely reflects the French policy to limit intrahospital spread of CP-GNB and VRE strains.
引用
- Grohs P, Vilfaillot A, Zahar JR, et al. Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study. J Antimicrob Chemother. 2022. PMID: 36031727. doi:10.1093/jac/dkac289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。